Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
주식 순위
#815
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
주가
$24.65
시가총액
$29.87B
변동 (1일)
0.19%
변동 (1년)
-21.48%
국가
CN
거래 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
카테고리
Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)의 수익
Jun 2026 기준 수익 TTM: $1.35B
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $1.35B입니다. 2023년에 회사는 $1.84B의 수익을 올렸으며 이는 2022년의 수익 $1.59B과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.의 수익 기록 (2014 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.35B | -24.34% |
| 2024 | $1.78B | -2.96% |
| 2023 | $1.84B | 15.75% |
| 2022 | $1.59B | 11.93% |
| 2021 | $1.42B | 24.59% |
| 2020 | $1.14B | 47.70% |
| 2019 | $770.94M | 25.12% |
| 2018 | $616.16M | 36.76% |
| 2017 | $450.55M | 68.95% |
| 2016 | $266.68M | 58.95% |
| 2015 | $167.78M | -28.63% |
| 2014 | $235.08M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $7.51B | 456.53% |
US
|
|
| $5.56B | 312.19% |
IE
|
|
| $5.15B | 281.44% |
US
|
|
| $3.86B | 186.08% |
US
|
|
| - | - |
DE
|
